Work

Anticoagulant Therapy For Acute Coronary Syndromes

Year: 2018

Type: article

Abstract: Anticoagulation in conjunction with antiplatelet therapy is central to the management of acute coronary syndromes (ACS). When used effectively it is associated with a reduction in recurrent ischaemic events including myocardial infarction and stent thrombosis as well as a reduction in death. Effective ischaemic risk reduction whilst balancing bleeding risk remains a clinical challenge. This article reviews the current available evidence for anticoagulation in ACS and recommendations from the European Society of Cardiology.

Source: Interventional Cardiology Reviews Research Resources

DOI: 10.15420/icr.2017:26:1

Authors: Eunice NC Onwordi, Amr Gamal, Azfar Zaman

Institutions: Portsmouth Hospitals NHS Trust, Freeman Hospital, Newcastle University

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $2,146